Resource Central is a product of the Pediatric Pandemic Network.

Nirsevimab Library

This is a collection of current resources related to Nirsevimab.

7180 of over 100 results

Applied Filters:

Respiratory Syncytial Virus-Induced Disease in Healthy Infants: We Need to Offload This Burden
2023 · University of Amsterdam
This 2-page comment discusses the impact of respiratory syncytial virus (RSV) on infants, highlighting its significant health burden. It notes that RSV causes severe respiratory …
Respiratory Syncytial Virus-An Update for Prenatal and Primary Health Providers
2023 · University of Washington, · State University of New York - Upstate Medical University, · Seattle Children's Hospital
This article provides an update on respiratory syncytial virus (RSV) for prenatal and primary health providers. It emphasizes the lack of data on RSV infection …
Respiratory Syncytial Virus Infection: Old Challenges and New Approaches
2023 · St. Jude Children's Research Hospital, · Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), · Nationwide Children's Hospital
This article discusses respiratory syncytial virus (RSV), a major threat to child health causing acute and long-term morbidity. It explains the structure and function of …
For Indigenous Infants, RSV Prevention is Better Than a Cure
2023 · University of Toronto
This article discusses the importance of preventing respiratory syncytial virus (RSV) in Indigenous infants, particularly focusing on the high rates of RSV-related hospital admissions among …
The Beginning of a New Era in RSV Control
2023 · Dartmouth-Hitchcock Medical Center
This commentary discusses the historical development and recent advancements in RSV control, focusing on antiviral therapy, passive immunoprophylaxis, and vaccines. It highlights the licensing of …
Implications of Food and Drug Administration Approval of Respiratory Syncytial Virus Prophylactic Medication
2023 · Boston Children's Hospital, · Stony Brook Children's Hospital
This brief article discusses the implications of the FDA approval of nirsevimab, a monoclonal antibody, for preventing respiratory syncytial virus (RSV) lower respiratory tract infections …
Update on Vaccines in Antenatal Care
2024 · St. George's University of London, · St. George's University Hospitals NHS Foundation Trust
This article is about vaccines for pregnant women to protect them and their babies from diseases. It describes the importance of vaccines like flu, pertussis, …
Respiratory Syncytial Virus Immunoprophylaxis: Novel Opportunities and a Call for Equity
2024 · Poznan University of Medical Sciences, · University of Kassel
This article discusses new ways to prevent respiratory syncytial virus (RSV) infections, especially in infants and the elderly. It describes how 2023 was important because …
Respiratory Syncytial Virus Vaccination Recommendations and Other Updates From ACIP
2023 · University of Michigan
This 2-page practice guideline highlights the impact of respiratory syncytial virus (RSV) infection in the United States, causing severe respiratory illness, especially in infants and …
Access to Respiratory Syncytial Virus Preventive Tools for Neonates and Infants in Europe
2024 · Charité – Universitätsmedizin Berlin, · London School of Hygiene & Tropical Medicine
This comment discusses the limited access to respiratory syncytial virus (RSV) preventive tools for newborns and infants in Europe. RSV causes millions of pneumonia cases …

Looking for different way to find resources?

Our chatbot aRCie can help with a more personalized search. Click below to try our new chatbot.

Try aRCie
7180 of over 100 results